GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (FRA:R0V) » Definitions » 3-Year EBITDA Growth Rate

Revenio Group Oyj (FRA:R0V) 3-Year EBITDA Growth Rate : 11.70% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revenio Group Oyj 3-Year EBITDA Growth Rate?

Revenio Group Oyj's EBITDA per Share for the three months ended in Mar. 2024 was €0.24.

During the past 12 months, Revenio Group Oyj's average EBITDA Per Share Growth Rate was -12.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 11.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 22.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 21.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Revenio Group Oyj was 118.10% per year. The lowest was -64.70% per year. And the median was 18.50% per year.


Competitive Comparison of Revenio Group Oyj's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Revenio Group Oyj's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's 3-Year EBITDA Growth Rate falls into.



Revenio Group Oyj 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Revenio Group Oyj  (FRA:R0V) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Revenio Group Oyj 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (FRA:R0V) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (FRA:R0V) Headlines

No Headlines